Home
Products
Learn
About
Pricing
Log In
Back
CUSN

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Copper Search Limited

πŸ‡¦πŸ‡Ί ASX

πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

3
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Copper Search Limited - Ordinary Fully Paid Deferred

πŸ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in CUSN

3

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in CUSN

N/A
CUSN investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

33%

100k - 150k

50k - 100k

67%

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
πŸ™‹ Legal gender of investors

Female

67%

Male

33%

Pearlers who invest in CUSN also invest in...

Copper Search Limited

CUS

Copper Search Ltd. is a mineral exploration and development company focused on the Gawler Craton Region of South Australia. The firm is engaged in targeting the copper-gold deposits within the Gawler Craton of South Australia. The Company’s flagship Peake Project is in the NE Gawler Craton which is prospective for large-scale copper (IOCG) deposits. The company has over 20 shallow potential IOCG targets less than 500 meters (m) deep and a further six deeper targets at the project. The Project has been endowed with over 100 million tons of copper and 110 million ounces of gold. The project covers over 5,000 square kilometers. Its tenements are held through its 100%-owned subsidiary, Copper Search Australia Pty Ltd. Its tenements include Curdimurka, Anna Creek, Allandale, Stuarts Creek, Callana, Ruby Hill, Spring Hill, Mt Denison, and Blyth Creek. Its drilling aims to identify IOCG target deposits with similar scale potential to Prominent Hill and Carrapateena.

πŸ“Š Share price

$0.02 AUD

⛏️ MINING

Find Out More

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

6.11%

πŸ“Š Share price

$69.51 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

15.99%

πŸ“Š Share price

$139.29 AUD

🌏 GLOBAL

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 7314.93m in AUM and 198 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

πŸ™Œ Performance (5Yr p.a)

8.36%

πŸ“Š Share price

$142.86 AUD

πŸ‡¦πŸ‡Ί AUSTRALIA

πŸ’Έ FINANCIALS

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

VGE.AX was created on 2013-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Seeks to track the return of the FTSE Emerging Markets All Cap China A Inclusion Index in Australian dollars, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

5.88%

πŸ“Š Share price

$81.69 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

Want more shares? Try these...

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-02-13. The firm is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).

πŸ™Œ Performance (5Yr p.a)

-11.33%

πŸ“Š Share price

$10.30 AUD

🧬 BIOTECHNOLOGY